Estrogen use and bone health in women with cystic fibrosis
Treatments studied
Part of Bones, joints & muscles, Digestive system, Genetic & congenital, Hormones & metabolism, Lungs & breathing clinical trials.
This observational study looks at how taking (or not taking) estrogen affects bone health in women with cystic fibrosis (CF). If you may have low estrogen, it also explores whether estrogen levels and symptoms relate to bone density over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cystic fibrosis (CF) diagnosis
- You are female and have had at least one menstrual period
- You plan to use the same estrogen plan for the whole study (either the same estrogen product or none)
- You are not pregnant and do not plan to become pregnant during the study
- You have not used anti-osteoporosis medicines like bisphosphonates, teriparatide, or denosumab
- If you join the extra feasibility part: you are under 35 and have been more than 2 years after your first period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for signs (markers) of bone thinning—called osteoporosis—in people with cystic fibrosis. Your participation may help researchers understand how osteoporosis develops in CF and whether a bone-strengthening medicine like denosumab could help, since some participants may need that medication.
This study looks at how cystic fibrosis affects bone health and bone marrow in teenagers. It uses a special MRI scan to measure bone strength and marrow composition, which may help doctors better understand and prevent bone problems in people with CF.
This study looks at how the body processes a mixed meal in people with cystic fibrosis who are on CFTR modulator therapy. It may help researchers understand how these medications change hormone and blood sugar responses.
This study looks at how where your body stores fat may be linked to changes in metabolism and lung function over time in people with cystic fibrosis. It also compares results with healthy people similar in age, sex, and body size to understand the differences better.
This study measures how CFTR medicine behaves in the body during pregnancy and after delivery while breastfeeding. The results may help confirm dosing and safety information for people with cystic fibrosis.
This study tests how estrogen treatment affects bone strength in young women with Functional Hypothalamic Amenorrhea (FHA), a condition where periods stop due to stress, low weight, or over-exercise. Participants who have had very few periods will receive estrogen to see if it improves bone density.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.